The Use of Enoxacin (B-Mark(TM)) in Urinary Tract Infections.
- Author:
Hong Woo KIM
1
;
Jun Ho CHANG
Author Information
1. East City Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
enoxacin;
urinary tract infection;
cystitis
- MeSH:
Cystitis;
Dyspepsia;
Enoxacin*;
Nausea;
Urethritis;
Urinary Tract Infections*;
Urinary Tract*
- From:Korean Journal of Urology
1988;29(1):133-141
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
A new synthetic pyridone carboxylic antimicrobial agent, Enoxacin (B-Mark(TM)) was administered orally in 37 cases of genitourinary tract infection and following results were obtained. 1. Among 12 cases of acute simple cystitis, the cure rate was 91.7%. 2. Among 6 cases of chronic complicated urinary tract infections, the cure rate was 66.7 %. 3. Among 9 cases of gonorrheal urethritis, the cure rate was 88.9%. 4. Among 10 cases of nongonorrheal urethritis, the cure rate was 60%. There was no serious side effects but mild G-I symptoms such as nausea, indigestion and fatigability were found. The results suggest that Enoxacin (B-Mark(TM)) is a useful antibacterial agent in the treatment of urinary tract infections, especially in acute simple cystitis and gonorrheal urethritis.
